In this issue:
Dapagliflozin in acute HF
ARNI vs. placebo in congenital systemic right ventricular HF
Contemporary use and implications of β-blockers in HFMREF/HFPEF
Managing iron deficiency in Asian HF patients
β-blocker withdrawal and functional capacity improvement in HFPEF
Phenotyping HF by genetics and associated conditions
Impact of visit volume on effectiveness of electronic tools to improve HF care
Pharmacological treatments in HFMREF/HFPEF
Dementia risk with statins in HF
Impact of rapid up-titration of GDMT on QOL in acute HF
Please login below to download this issue (PDF)